Establishment of palbociclib resistant metastatic breast cancer patient-derived xenograft models
Identify therapeutic vulnerabilities of palbociclib resistance in metastatic breast cancer patient-derived xenograft models and identify key biomarkers that correlate with development of resistance to inform new treatment directions Overall design: Comparative gene expression profiling analysis of RNA-seq data of palbociclib resistant patient-derived xenograft